Caladrius Biosciences, Inc. 4
4 · Caladrius Biosciences, Inc. · Filed Jan 11, 2017
Insider Transaction Report
Form 4
Preti Robert A
See Remarks
Transactions
- Tax Payment
Common Stock
2017-01-09$3.54/sh−2,482$8,786→ 43,142 total - Award
Common Stock
2017-01-09+18,300→ 45,624 total - Award
Stock Option
2017-01-09+27,500→ 27,500 totalExercise: $3.54From: 2017-01-09Exp: 2027-01-09→ Common Stock (27,500 underlying)
Footnotes (3)
- [F1]Represents 18,300 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan. 25% of the shares of restricted stock vest immediately on the grant date and the remaining 75% of the shares of restricted stock will vest annually over the following three years.
- [F2]Includes 17,993 shares of unvested restricted stock.
- [F3]25% of the shares underlying the stock options vest immediately on the grant date and the remaining 75% of the shares underlying the stock options will vest annually over the following three years.